Trademark Details For ANADROXIN (Serial Number 87545379)

  •  Home
  •  Print
ANADROXIN
0
0
0
0
Serial Number  United States - USPTO 87545379
Registration Number 5391976
Mark
ANADROXIN
Filing Date Jul-27-2017
Status
Registered  
SECTION 8-AC.. (701)
SECTION 8-ACCEPTED
Attorney Name
TTAB
0




005Pharmaceuticals

U.S Class(es): 006, 018, 044, 046, 051, 052

Class Status: Active

First Use: Jul-19-2017

First Use in Commerce: Jul-19-2017





Correspondences

NameJavier Gomez
AddressMarkavo.com 5473 Blair Rd Ste 100 PMB 72065 Dallas,TX 75231-4101

Prosecution History

DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Jul-31-2017NEW APPLICATION ENTERED   NWAPI
Aug-01-2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Sep-29-2017ASSIGNED TO EXAMINER   DOCKD
Sep-29-2017APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Oct-25-2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Nov-14-2017PUBLISHED FOR OPPOSITION   PUBOA
Nov-14-2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Jan-30-2018REGISTERED-PRINCIPAL REGISTER   R.PRA
May-10-2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED   REAPI
May-10-2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED   ARAAI
May-15-2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP   ASGNI
Jan-30-2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED   REM1E
Dec-06-2023TEAS SECTION 8 RECEIVED   ES8RI
Feb-07-2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Feb-07-2024REGISTERED - SEC. 8 (6-YR) ACCEPTED   8.OKO
Feb-07-2024NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED   NAS8E